NCT05143307View on ClinicalTrials.gov

Long-Term Follow-Up Study of HIV-1 Infected Adults Who Received EBT-101

PHASE1Enrolling by invitationINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

July 11, 2023

Primary Completion Date

January 31, 2037

Study Completion Date

April 30, 2037

Conditions
HIV-1-infection
Interventions
BIOLOGICAL

EBT-101

Long term follow up of participants who received EBT-101

Trial Locations (3)

63110

Washington University, St Louis

94115

Quest Clinical Research, San Francisco

08103

Cooper Health, Camden

Sponsors
All Listed Sponsors
lead

Excision BioTherapeutics

INDUSTRY